Needlework
发表于 2025-3-23 09:41:47
http://reply.papertrans.cn/25/2415/241458/241458_11.png
EPT
发表于 2025-3-23 14:18:03
Antidepressant-induced switch and outcome to lithium prophylaxis in bipolar patientsto mania or viceversa (1). Bunney reviewed 80 studies involving 3923 patients treated with tricyclic antidepressants or monoamineoxidase inhibitors and found that 9.6 per cent of these patients had switched from depression to mania or hypomania during the treatment (1). Recently it was reported that
勤勉
发表于 2025-3-23 21:25:57
http://reply.papertrans.cn/25/2415/241458/241458_13.png
Glossy
发表于 2025-3-23 23:13:32
http://reply.papertrans.cn/25/2415/241458/241458_14.png
consolidate
发表于 2025-3-24 06:16:38
http://reply.papertrans.cn/25/2415/241458/241458_15.png
sundowning
发表于 2025-3-24 10:27:52
Does lithium prevent the development of dopamine receptor supersensitivity? Behavioural studiestecho1 ami ne hypothesis, thus extending it to the receptor level (4). Their idea was based on clinical observation that dopamine receptor antagonists (neuro1epties) acutely suppress manic symptomatology, while dopamine agonists (such as piribedil and 1-Dopa) can precipitate manic episodes in certai
南极
发表于 2025-3-24 11:16:45
Lithium treatment in schizoaffective patientsore, there has been a great deal of debate as to its meaning and validity (3) and it has even been suggested that the term has created more mischief than it has resolved confusion (4). Anyhow, even contemporary trends in psychiatry reveal the continued influence of the Kraeplinian dichotomy in the p
buoyant
发表于 2025-3-24 17:23:48
http://reply.papertrans.cn/25/2415/241458/241458_18.png
先锋派
发表于 2025-3-24 21:56:17
Conference proceedings 1984th some recent clinical studies on rubidium. This volume should be an invaluable aid to all psychiatrists and those who work in the field of research of these pharmacological active metals. G. U. Corsini List of contributors A. ALCIATI L. BELLODI Institute of Clinical Psychiatry Institute of Clinica
LIEN
发表于 2025-3-24 23:58:55
ncerned with some recent clinical studies on rubidium. This volume should be an invaluable aid to all psychiatrists and those who work in the field of research of these pharmacological active metals. G. U. Corsini List of contributors A. ALCIATI L. BELLODI Institute of Clinical Psychiatry Institute of Clinica978-94-011-7320-9978-94-011-7318-6